Human Metabolome Technologies, Inc.
6090
Rank in Stocks
#26549
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Share Price
$3.60
Last synced: 2026-11-10
Market Cap
$19.49M
Change (1 day)
0.53%
Change (1 year)
-15.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Human Metabolome Technologies, Inc. (6090)
Category
Healthcare
Operating Margin for Human Metabolome Technologies, Inc. (6090)
Operating Margin as of November 2026 TTM: 14.76%
According to Human Metabolome Technologies, Inc.'s latest financial reports, its current operating margin (TTM) is 14.76%. At the end of 2025 the company had an operating margin of 17.11%.
Operating Margin history for Human Metabolome Technologies, Inc. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.76% | -13.73% |
| 2025 | 17.11% | 4.58% |
| 2024 | 16.36% | 0.74% |
| 2023 | 16.24% | 3.90% |
| 2022 | 15.63% | 346.57% |
| 2021 | 3.50% | -330.26% |
| 2020 | -1.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -97.39% |
US
|
|
| -149.01% | -110.10% |
US
|
|
| 25.57% | -98.27% |
AU
|
|
| 31.23% | -97.88% |
BE
|
|
| 29.35% | -98.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Human Metabolome Technologies, Inc.'s operating margin
What is Human Metabolome Technologies, Inc.'s operating margin?
Human Metabolome Technologies, Inc.'s operating margin is 14.76%, as of Nov 2026.
What was Human Metabolome Technologies, Inc.'s operating margin in 2025?
In 2025, Human Metabolome Technologies, Inc.'s operating margin was 17.11%, compared with 16.36% in 2024.
How has Human Metabolome Technologies, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Human Metabolome Technologies, Inc.'s operating margin was highest in 2025 (17.11%) and lowest in 2020 (-1.52%).
How does Human Metabolome Technologies, Inc.'s operating margin compare with similar companies?
Human Metabolome Technologies, Inc.'s operating margin (14.76%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.